Filter
1436
Text search:
ARV
Featured
102
544
Language
Document type
1060
135
109
40
34
22
22
7
5
1
1
Countries / Regions
65
58
48
43
43
43
43
42
40
39
37
29
26
26
22
21
20
20
19
19
19
19
18
18
17
17
16
16
16
15
14
12
12
11
10
10
9
9
8
7
7
6
6
6
6
5
5
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
908
67
63
44
26
16
1
Toolboxes
289
96
23
20
14
14
13
13
9
8
8
6
5
4
4
3
2
2
2
1
1
Le Ministère de la Santé (MS), dans le cadre de la démarche qualité au niveau du secteur, s’est engagé depuis quelques années dans la normalisation des activités par l’élaboration et la mise en place de documents normatifs. C’est le cas du présent document de politique, normes et proc
...
Le Bénin est un pays à épidémie mixte car il existe des poches de concentration de fortes prévalences
au sein de certaines populations clés plus exposées aux risques d’infection, notamment les TS et
leurs partenaires, les prisonniers, les HSH et les UDI. Les sections suivantes présentero
...
Annuaire des Statistiques Sanitaires
UNAIDS/WHO Working group
HIV/AIDS and STI surveillance 2015 / Reference
Accessed on 28.02.2020
Masangane Case Study
The Vesper Society commissioned ARHAP to do research on the integrated Masangane HIV/AIDS programme affiliated with the Moravian Church in Eastern Cape, South Africa. Completed in 2006, this study aimed to understand the role of the religious health assets of the Masangane ART
...
Document outcomes of women and their babies with COVID-19 in pregnancy
Medicines and medical devices for 10 000 people for approximately three months
6th edition. The HIV epidemic Namibia is gradually being brouhgt under countrol as demonstrated by results in the preliminary report of Namibia Population-Based HIV Impact Assessment (NAMPHIA), a cross-sectional household-based survey that was conducted in 2017. Currently, it is estimated that about
...
ATIC Newsletter, Vol 15, Issue 1,
February 2022.
Panels Recommendation Updated Dec 2024
These guidelines were developed through an interagency process with participation by United Nations (UN) organiza-
tions, nongovernmental organizations, the International Red Cross and Red Crescent Movement and the International
Organization for Migration.
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
